Core Viewpoint - A class action securities lawsuit has been filed against Jayud Global Logistics Limited, alleging securities fraud that affected investors between April 21, 2023, and April 30, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Jayud was involved in a fraudulent stock promotion scheme characterized as a "pump-and-dump," utilizing misinformation on social media and impersonation of financial professionals [4]. - It is alleged that insiders or affiliates used offshore or nominee accounts to facilitate the coordinated selling of shares during a price inflation campaign [4]. - The company's public statements and risk disclosures reportedly failed to mention the false rumors and artificial trading activity that inflated the stock price, leading to materially misleading statements about Jayud's business and prospects [4]. Group 2: Legal Process and Participation - The case is identified as Lindstrom v. Jayud Global Logistics Limited, et al., Case No. 25-cv-09662 [5]. - Investors who suffered losses during the specified timeframe have until January 20, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [5]. Group 3: Law Firm Background - Kahn Swick & Foti, LLC, the law firm handling the case, is recognized as one of the leading boutique securities litigation firms in the U.S., with a ranking among the top 10 firms nationally based on total settlement value [5]. - The firm represents a diverse clientele, including public and private institutional investors, as well as retail investors, in seeking recoveries for investment losses due to corporate fraud [5].

Core Viewpoint - Fermi Inc. is facing a class action lawsuit due to alleged violations related to its October 2025 IPO, with claims of misleading statements regarding tenant demand and funding commitments for its Project Matador campus [1][3][4]. Company Overview - Fermi Inc. is described as an energy and AI infrastructure company that conducted an IPO in October 2025, selling 37,375,000 shares at $21.00 per share [2]. Allegations of the Lawsuit - The lawsuit alleges that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment, which posed a significant risk of termination [3]. - On December 12, 2025, Fermi disclosed that the first tenant for Project Matador had terminated a $150 million funding agreement, leading to a nearly 34% drop in stock price [4]. - By the time the lawsuit commenced, Fermi's stock price had fallen to as low as $8.59 per share, representing a 59% decline from the IPO price [5]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Fermi common stock during the IPO or the class period to seek appointment as lead plaintiff in the lawsuit [6]. - The lead plaintiff will represent the interests of all class members and can choose a law firm for litigation [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [7].

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding delinquency rates in private education loans [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff by February 17, 2026 [1]. - The lawsuit is titled Zappia v. SLM Corporation and is filed in the District of New Jersey [1]. - The allegations include that SLM experienced a significant increase in early-stage delinquencies, which was not disclosed to investors [3]. Group 2: Allegations and Impact - A report from TD Cowen on August 14, 2025, indicated that July 2025 delinquencies rose by 49 basis points month-over-month, contradicting SLM's CFO's earlier statements about normal seasonal trends [4]. - Following the TD Cowen report, SLM's stock price dropped by approximately 8%, reflecting investor reaction to the disclosed delinquency issues [4]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who suffered losses during the class period to seek lead plaintiff status, which enables them to direct the lawsuit on behalf of all class members [5]. - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [6].

Company Overview - Travere Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for individuals with rare kidney and metabolic diseases in the United States [2]. Investigation Details - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws related to Travere, specifically whether the company and its executives made materially false and/or misleading statements or omitted important information regarding its business and operations [1][2]. Law Firm Background - Robbins Geller is recognized as one of the leading law firms in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in securities-related class action cases in 2024 alone, which is more than the next five law firms combined [3].

Core Viewpoint - Klarna Group plc is facing a class action lawsuit related to its September 10, 2025 IPO, alleging violations of the Securities Act of 1933 due to misleading offering documents and understated risk regarding loss reserves [1][3]. Company Overview - Klarna provides payment, advertising, and digital retail banking solutions to consumers and merchants [2]. - The company conducted its IPO on September 10, 2025, issuing approximately 34 million shares at an offering price of $40.00 per share [2]. Allegations of the Lawsuit - The lawsuit claims that Klarna's IPO offering documents were materially false and misleading, particularly regarding the risk of increased loss reserves shortly after the IPO [3]. - Following the IPO, a Bloomberg News article reported that Klarna posted a net loss of $95 million and increased provisions for loan losses to $235 million, exceeding analyst estimates [4]. - By the time the class action lawsuit commenced, Klarna's stock price had dropped to $31.31 per share, significantly below the IPO price [4]. Legal Process - Investors who purchased Klarna securities can seek appointment as lead plaintiff in the class action lawsuit, which allows them to act on behalf of other class members [5]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect the ability to share in any potential recovery [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [6].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices by Inovio Pharmaceuticals and its officers/directors, following a significant stock price drop after FDA news regarding its drug application [1][4]. Group 1: FDA Announcement and Stock Impact - On December 29, 2025, the FDA accepted Inovio's Biologics License Application for INO-3107, a treatment for recurrent respiratory papillomatosis, but did not find sufficient information for accelerated approval [3]. - Inovio's stock price fell by $0.56, or 24.45%, closing at $1.73 per share on the same day [4]. Group 2: Legal Investigation - Pomerantz LLP is reaching out to investors of Inovio regarding claims of potential securities fraud and is encouraging them to contact the firm for further information [1].

Boston, Massachusetts--(Newsfile Corp. - January 13, 2026) - Block & Leviton announces that a securities fraud lawsuit has been filed against Klarna Group plc (NYSE: KLAR) and certain of its executives. Investors who have lost money in their Klarna Group investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/klar.What is this all about?Klarna Group conducted its IPO at $40 per share on September 10, 2025. The compla ...

Core Viewpoint - A class action lawsuit has been filed against Klarna Group PLC, alleging securities fraud and unlawful business practices by the company and its officers [2][3]. Group 1: Lawsuit Details - Investors are encouraged to contact Pomerantz LLP for participation in the class action, with a deadline of February 20, 2026, to apply as Lead Plaintiff [3]. - The lawsuit arises from Klarna's initial public offering (IPO) and subsequent financial disclosures that raised concerns about the company's business practices [2][4]. Group 2: Financial Performance - Klarna conducted its IPO on September 10, 2025, offering 34,311,274 shares at $40 each [4]. - Following the IPO, Klarna reported a net loss of $95 million, with provisions for credit losses amounting to $235 million, exceeding analyst expectations of $215.8 million [4]. - Provisions for credit losses represented 0.72% of gross merchandise volume, an increase from 0.44% the previous year [4]. - As of December 22, 2025, Klarna's stock closed at $31.31, which is below the IPO price [4]. Group 3: Market Context - The company faces scrutiny over customer loan defaults, particularly within its buy now, pay later (BNPL) business model, which has been criticized for targeting younger individuals with lower financial security [4]. - Research from the Richmond Fed indicates that BNPL customers typically have riskier credit profiles, being younger, less-educated, and carrying higher debt burdens [4].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Apogee Enterprises, Inc. and its officers or directors [1] Financial Performance - On January 7, 2025, Apogee reported third-quarter financial results for the 2026 fiscal year, with sales of $355.3 million, which fell short of the consensus estimate of $348.6 million [3] - The CEO attributed the disappointing results to "higher aluminum, restructuring and health insurance costs" [3] - Following the announcement, Apogee's stock price decreased by $5.18 per share, or 13.89%, closing at $32.11 per share on January 7, 2026 [3]

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving First Solar, Inc. and its officers or directors [1] Group 1: Company Performance - Jefferies downgraded First Solar from Buy to Hold on January 7, 2026, citing lowered guidance, significant de-bookings, and margin compression throughout 2025 [3] - Following the downgrade, First Solar's stock price decreased by $27.67, or 10.29%, closing at $241.11 per share on January 7, 2026 [3] Group 2: Legal Investigation - Pomerantz LLP is representing investors of First Solar in an investigation regarding possible securities fraud or other unlawful business practices [1] - The firm has a long history of handling corporate, securities, and antitrust class litigation, recovering multimillion-dollar damages for victims of securities fraud [4]